Provided by Tiger Fintech (Singapore) Pte. Ltd.

DiaMedica Therapeutics Inc.

4.17
+0.21005.30%
Volume:89.32K
Turnover:364.70K
Market Cap:178.71M
PE:-6.89
High:4.20
Open:3.98
Low:3.98
Close:3.96
Loading ...

Diamedica Therapeutics (DMAC) Gets a Buy from Lake Street

TIPRANKS
·
19 Mar

DiaMedica Therapeutics Inc. : H.c. Wainwright Raises Target Price to $10 From $7

THOMSON REUTERS
·
19 Mar

DiaMedica Therapeutics Inc (DMAC) Q4 2024 Earnings Call Highlights: Strong Financial Position ...

GuruFocus.com
·
19 Mar

Q4 2024 DiaMedica Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
19 Mar

DiaMedica Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Mar

DiaMedica Therapeutics: Preeclampsia Phase 2 Trial Preliminary Topline Safety, Efficacy Data From Part 1a of Study Expected in Q2 2025

THOMSON REUTERS
·
18 Mar

Press Release: DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results

Dow Jones
·
18 Mar

Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics

Simply Wall St.
·
17 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

DiaMedica Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
15 Mar

Press Release: DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025

Dow Jones
·
11 Mar

Insiders At DiaMedica Therapeutics See Good Returns After Buying Stock Worth US$9.00m

Simply Wall St.
·
08 Mar

DiaMedica Therapeutics Appoints Daniel J. O’connor to the Board of Directors

THOMSON REUTERS
·
24 Feb

DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors

Business Wire
·
24 Feb

DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Business Wire
·
11 Feb

Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$43m

Simply Wall St.
·
29 Dec 2024

Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$26m

Simply Wall St.
·
19 Dec 2024

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Diamedica Therapeutics (DMAC)

TIPRANKS
·
16 Dec 2024

DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of Dm199 for the Treatment of Preeclampsia

THOMSON REUTERS
·
03 Dec 2024

DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia

Business Wire
·
03 Dec 2024